DK3094616T3 - Anvendelsen af glyceryltribenzoat-indeholdende sammensætning i neurodegenerative lidelser - Google Patents
Anvendelsen af glyceryltribenzoat-indeholdende sammensætning i neurodegenerative lidelser Download PDFInfo
- Publication number
- DK3094616T3 DK3094616T3 DK15737329.1T DK15737329T DK3094616T3 DK 3094616 T3 DK3094616 T3 DK 3094616T3 DK 15737329 T DK15737329 T DK 15737329T DK 3094616 T3 DK3094616 T3 DK 3094616T3
- Authority
- DK
- Denmark
- Prior art keywords
- containing composition
- neurodegenerative disorders
- glyceryl tribenzoate
- tribenzoate
- glyceryl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461928622P | 2014-01-17 | 2014-01-17 | |
| PCT/US2015/011798 WO2015109215A1 (en) | 2014-01-17 | 2015-01-16 | The use of a benzoate containing composition in urea cycle disorders and neurodegenerativre disordrs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3094616T3 true DK3094616T3 (da) | 2021-02-15 |
Family
ID=53543490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15737329.1T DK3094616T3 (da) | 2014-01-17 | 2015-01-16 | Anvendelsen af glyceryltribenzoat-indeholdende sammensætning i neurodegenerative lidelser |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9968582B2 (da) |
| EP (1) | EP3094616B1 (da) |
| JP (2) | JP6836905B2 (da) |
| CA (1) | CA2936548C (da) |
| CY (1) | CY1124115T1 (da) |
| DK (1) | DK3094616T3 (da) |
| ES (1) | ES2853974T3 (da) |
| HR (1) | HRP20210361T1 (da) |
| HU (1) | HUE053671T2 (da) |
| LT (1) | LT3094616T (da) |
| PL (1) | PL3094616T3 (da) |
| PT (1) | PT3094616T (da) |
| RS (1) | RS61611B1 (da) |
| SI (1) | SI3094616T1 (da) |
| WO (1) | WO2015109215A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018345244A1 (en) * | 2017-10-06 | 2020-04-02 | Rush University Medical Center | The use of a benzoate containing composition to treat glycine encephalopathy |
| WO2019103597A1 (en) * | 2017-11-22 | 2019-05-31 | Excelsior Pharmatech Labs | Benzoic acid or a salt and derivative thereof for use in preventing or treating depression |
| EP3930704A4 (en) * | 2019-02-25 | 2022-11-16 | Rush University Medical Center | COMPOSITIONS WITH CINNANIC ACID AND PROCESS FOR THE PREPARATION THEREOF |
| WO2021011500A2 (en) * | 2019-07-16 | 2021-01-21 | Rush University Medical Center | Use of a benzoate containing composition to treat neurodegenerative disorders |
| EP4236966A1 (en) * | 2020-10-28 | 2023-09-06 | Rush University Medical Center | Use of a cinnamein composition for the treatment of glycine encephalopathy and urea cycle disorders |
| EP4262781A1 (en) * | 2020-12-16 | 2023-10-25 | Rush University Medical Center | Administration of glycerol tribenzoate and glycerol phenylbutyrate for treatment of neurodegenerative and urea cycle disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284647A (en) | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| US20080171792A1 (en) | 2006-12-28 | 2008-07-17 | Jobdevairakkam Christopher New | Use of highly concentrated formulations of 4-phenylbutyrate for treatment of certain disorders |
-
2015
- 2015-01-16 PL PL15737329T patent/PL3094616T3/pl unknown
- 2015-01-16 RS RS20210230A patent/RS61611B1/sr unknown
- 2015-01-16 EP EP15737329.1A patent/EP3094616B1/en active Active
- 2015-01-16 SI SI201531511T patent/SI3094616T1/sl unknown
- 2015-01-16 LT LTEP15737329.1T patent/LT3094616T/lt unknown
- 2015-01-16 WO PCT/US2015/011798 patent/WO2015109215A1/en active Application Filing
- 2015-01-16 DK DK15737329.1T patent/DK3094616T3/da active
- 2015-01-16 PT PT157373291T patent/PT3094616T/pt unknown
- 2015-01-16 ES ES15737329T patent/ES2853974T3/es active Active
- 2015-01-16 CA CA2936548A patent/CA2936548C/en active Active
- 2015-01-16 JP JP2016565117A patent/JP6836905B2/ja active Active
- 2015-01-16 US US15/110,702 patent/US9968582B2/en active Active
- 2015-01-16 HU HUE15737329A patent/HUE053671T2/hu unknown
-
2019
- 2019-10-18 JP JP2019191224A patent/JP2020037558A/ja active Pending
-
2021
- 2021-03-03 HR HRP20210361TT patent/HRP20210361T1/hr unknown
- 2021-03-09 CY CY20211100204T patent/CY1124115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI3094616T1 (sl) | 2021-07-30 |
| JP2017505811A (ja) | 2017-02-23 |
| EP3094616A1 (en) | 2016-11-23 |
| CY1124115T1 (el) | 2022-05-27 |
| JP6836905B2 (ja) | 2021-03-03 |
| RS61611B1 (sr) | 2021-04-29 |
| WO2015109215A1 (en) | 2015-07-23 |
| HUE053671T2 (hu) | 2021-07-28 |
| LT3094616T (lt) | 2021-04-12 |
| PT3094616T (pt) | 2021-03-03 |
| CA2936548C (en) | 2022-08-30 |
| EP3094616A4 (en) | 2017-08-23 |
| PL3094616T3 (pl) | 2021-05-31 |
| US9968582B2 (en) | 2018-05-15 |
| US20160331714A1 (en) | 2016-11-17 |
| CA2936548A1 (en) | 2015-07-23 |
| EP3094616B1 (en) | 2020-12-23 |
| ES2853974T3 (es) | 2021-09-20 |
| JP2020037558A (ja) | 2020-03-12 |
| HRP20210361T1 (hr) | 2021-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC3057969I2 (lt) | Kompozicijos, naudojamos gydyti sutrikimams, susijusiems su kit | |
| DK3334422T3 (da) | Anvendelse af cannabidiolsyre i behandling af epilepsi | |
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3811943T3 (da) | Forbindelse til anvendelse til behandling af øjenlidelser | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| BR112016026879A2 (pt) | Composição farmacêutica líquida | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| DK3102213T3 (da) | Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser | |
| DK3102555T3 (da) | Sammensætninger af forbindelser og anvendelser deraf | |
| DK3094322T3 (da) | Administration af tasimelteon i fastende tilstand | |
| DK3094616T3 (da) | Anvendelsen af glyceryltribenzoat-indeholdende sammensætning i neurodegenerative lidelser | |
| DK3278801T3 (da) | Farmaceutisk sammensætning indeholdende mirabegron | |
| BR112016027379A2 (pt) | formulações tópicas e seus usos | |
| DK3149049T3 (da) | Il-22 til anvendelse til behandling af stofskiftesygdomme | |
| DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
| DK3164116T3 (da) | Brusesammensætninger indeholdende co-krystaller af syredelen | |
| DK2944309T3 (da) | Anvendelse af palmitoylethanolamid i kombination med opioider | |
| FR3021528B1 (fr) | Formulation cosmetique | |
| KR20180084728A (ko) | 구강용 조성물 | |
| FR3039766B1 (fr) | Composition cosmetique exfoliante | |
| FR3026994B1 (fr) | Glissiere non deformable en cas d'accident | |
| DK3089740T3 (da) | Farmaceutisk sammensætning | |
| FR3032614B1 (fr) | Composition cosmetique nettoyante | |
| FR3026639B1 (fr) | Composition cosmetique | |
| DK3581180T3 (da) | Antimikrobielle sammensætninger med brusemidler |